Author | Suresh A. Ramalingam, MD | OncLive

Author | Suresh A. Ramalingam, MD

Articles

Dr. Ramalingam on Pembrolizumab and Chemotherapy in NSCLC

February 27, 2018

Video

Suresh A. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, discusses data with pembrolizumab (Keytruda) and chemotherapy in patients with non–small cell lung cancer (NSCLC).

x